MARKET

ATR

ATR

Aptargroup
NYSE
99.23
+1.79
+1.84%
After Hours: 99.23 0 0.00% 16:07 10/04 EDT
OPEN
99.09
PREV CLOSE
97.44
HIGH
99.83
LOW
98.51
VOLUME
262.85K
TURNOVER
0
52 WEEK HIGH
135.81
52 WEEK LOW
93.69
MARKET CAP
6.48B
P/E (TTM)
28.90
1D
5D
1M
3M
1Y
5Y
BRIEF-Aptar Announces Exclusive Collaboration Between Aptar Pharma And Fluidda
BRIEF-Aptar Announces Exclusive Collaboration Between Aptar Pharma And Fluidda
Reuters · 09/22 13:09
Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma And Fluidda
Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products (OINDPs), today announced an exclusive collaboration with Fluidda, a leader in the
Benzinga · 09/22 12:35
GEF vs. ATR: Which Stock Is the Better Value Option?
GEF vs. ATR: Which Stock Is the Better Value Option?
Zacks · 08/22 15:40
Insider Sell: Aptargroup
Insider Sell: Aptargroup
MT Newswires · 08/15 14:42
AptarGroup's (NYSE:ATR) investors will be pleased with their favorable 37% return over the last five years
The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...
Simply Wall St. · 08/07 12:40
Aptar Pharma Pays Pharmaxis $5M to Acquire Orbital Technology
Clinical stage drug developer Pharmaxis (ASX: PXS) today announced that Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, has exercised the option to acquire the worldwide rights to Pharmaxis' proprieta...
Benzinga · 08/04 08:52
--Morgan Stanley Adjusts AptarGroup's Price Target to $120 From $126, Maintains Equalweight Rating
--Morgan Stanley Adjusts AptarGroup's Price Target to $120 From $126, Maintains Equalweight Rating
MT Newswires · 08/02 10:49
--Baird Adjusts AptarGroup's Price Target to $110 From $125, Maintains Neutral Rating
--Baird Adjusts AptarGroup's Price Target to $110 From $125, Maintains Neutral Rating
MT Newswires · 08/01 09:15
More
About ATR
AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. Beauty + Home segment includes operations that sells dispensing systems and sealing solutions primarily to the beauty, personal care and home care markets. The Food + Beverage segment includes operations that sell dispensing systems and sealing solutions to the food and beverage markets. The Company also manufactures and sells elastomeric primary packaging components. Its components are used in the injectables market. Its products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials.

Webull offers kinds of AptarGroup, Inc. stock information, including NYSE:ATR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATR stock methods without spending real money on the virtual paper trading platform.